Stevens Lesley A, Coresh Josef, Schmid Christopher H, Feldman Harold I, Froissart Marc, Kusek John, Rossert Jerome, Van Lente Frederick, Bruce Robert D, Zhang Yaping Lucy, Greene Tom, Levey Andrew S
Division of Nephrology, Tufts-New England Medical Center, 750 Washington St, Box #391, Boston, MA 02111, USA.
Am J Kidney Dis. 2008 Mar;51(3):395-406. doi: 10.1053/j.ajkd.2007.11.018.
Serum cystatin C was proposed as a potential replacement for serum creatinine in glomerular filtration rate (GFR) estimation. We report the development and evaluation of GFR-estimating equations using serum cystatin C alone and serum cystatin C, serum creatinine, or both with demographic variables.
Test of diagnostic accuracy.
SETTING & PARTICIPANTS: Participants screened for 3 chronic kidney disease (CKD) studies in the United States (n = 2,980) and a clinical population in Paris, France (n = 438).
Measured GFR (mGFR).
Estimated GFR using the 4 new equations based on serum cystatin C alone, serum cystatin C, serum creatinine, or both with age, sex, and race. New equations were developed by using linear regression with log GFR as the outcome in two thirds of data from US studies. Internal validation was performed in the remaining one third of data from US CKD studies; external validation was performed in the Paris study.
GFR was measured by using urinary clearance of iodine-125-iothalamate in the US studies and chromium-51-EDTA in the Paris study. Serum cystatin C was measured by using Dade-Behring assay, standardized serum creatinine values were used.
Mean mGFR, serum creatinine, and serum cystatin C values were 48 mL/min/1.73 m(2) (5th to 95th percentile, 15 to 95), 2.1 mg/dL, and 1.8 mg/L, respectively. For the new equations, coefficients for age, sex, and race were significant in the equation with serum cystatin C, but 2- to 4-fold smaller than in the equation with serum creatinine. Measures of performance in new equations were consistent across the development and internal and external validation data sets. Percentages of estimated GFR within 30% of mGFR for equations based on serum cystatin C alone, serum cystatin C, serum creatinine, or both levels with age, sex, and race were 81%, 83%, 85%, and 89%, respectively. The equation using serum cystatin C level alone yields estimates with small biases in age, sex, and race subgroups, which are improved in equations including these variables.
Study population composed mainly of patients with CKD.
Serum cystatin C level alone provides GFR estimates that are nearly as accurate as serum creatinine level adjusted for age, sex, and race, thus providing an alternative GFR estimate that is not linked to muscle mass. An equation including serum cystatin C level in combination with serum creatinine level, age, sex, and race provides the most accurate estimates.
血清胱抑素C被提议作为估算肾小球滤过率(GFR)时血清肌酐的潜在替代指标。我们报告了仅使用血清胱抑素C以及血清胱抑素C、血清肌酐或二者与人口统计学变量结合来估算GFR的方程的开发与评估情况。
诊断准确性测试。
在美国3项慢性肾脏病(CKD)研究中筛选的参与者(n = 2980)以及法国巴黎的一个临床人群(n = 438)。
测量的GFR(mGFR)。
使用基于仅血清胱抑素C、血清胱抑素C、血清肌酐或二者与年龄、性别和种族结合的4个新方程估算GFR。新方程通过在美国研究三分之二的数据中以log GFR为结果进行线性回归得出。在美国CKD研究剩余三分之一的数据中进行内部验证;在巴黎研究中进行外部验证。
在美国研究中使用碘-125-碘肽酸盐的尿清除率测量GFR,在巴黎研究中使用铬-51-依地酸测量GFR。使用Dade-Behring检测法测量血清胱抑素C,使用标准化的血清肌酐值。
平均mGFR、血清肌酐和血清胱抑素C值分别为48 mL/min/1.73 m²(第5至95百分位数,15至95)、2.1 mg/dL和1.8 mg/L。对于新方程,在包含血清胱抑素C的方程中年龄、性别和种族的系数具有显著性,但比包含血清肌酐的方程中的系数小2至4倍。新方程的性能指标在开发数据集、内部验证数据集和外部验证数据集中是一致的。基于仅血清胱抑素C、血清胱抑素C、血清肌酐或二者与年龄、性别和种族结合的方程,估算GFR在mGFR的30%范围内的百分比分别为81%、83%、85%和89%。仅使用血清胱抑素C水平的方程在年龄、性别和种族亚组中产生的估算值偏差较小,在包含这些变量的方程中偏差有所改善。
研究人群主要由CKD患者组成。
仅血清胱抑素C水平提供的GFR估算值几乎与经年龄、性别和种族调整后的血清肌酐水平一样准确,从而提供了一种与肌肉量无关的替代GFR估算方法。包含血清胱抑素C水平以及血清肌酐水平、年龄、性别和种族的方程提供了最准确的估算值。